China begins clinical trials of first coronavirus vaccine

China has started clinical trials of its first vaccine developed to cure the novel coronavirus (COVID-19).

A team of researchers led by Chen Wei, the country’s top military bio-warfare expert, revealed Beijing has given the go-ahead to clinical trials of the coronavirus vaccine.

“Vaccine is the strongest scientific weapon to end the coronavirus,” she told state broadcaster CCTV.

“If China is the first country to invent such weapons and have our own patents, it shows the progress of our science and the image of a giant country.”

Also Read: Coronavirus death toll in China jumps to 3,226

Chen said the research team has also prepared for large-scale production of the vaccine.

The Recombinant Novel Coronavirus Vaccine was successfully developed following more than a month of research, including the study of the vaccines for Ebola.

Being a leading specialist in genetic engineering vaccines in China, she developed a medical spray during the SARS outbreak in 2003.

The product prevented around 14,000 medical workers from contracting the virus, said another state-media report.

She is also known in the country as the ‘terminator of Ebola’ for leading a team to create a vaccine against the fatal illness.

Speaking of fighting the novel coronavirus, Chen said: ‘The epidemic is like a military situation. The epicentre equals to the battlefield.’

Also Read: Top pharmaceuticals to co-develop potential coronavirus vaccine

The 54-year-old expert, also a Major General of the People’s Army, has been working on the coronavirus vaccine since arriving in Wuhan on January 26, according to the press.

Chen and her team were already developing a quicker way to screen the COVID-19 coronavirus from a tent in the epicenter on January 30, according to an official report from China.